A primer on cytokines: Sources, receptors, effects, and inducers

Clinical Microbiology Reviews

Volumn 10, Issue 4, 1997, Pages 742-780

  Curfs, J H A J ^a   Meis, J F G M ^a   Hoogkamp Korstanje, J A A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE GROWTH FACTOR; CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LEUKOTRIENE; TUMOR NECROSIS FACTOR;

CEREBROSPINAL FLUID; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PATHOGENESIS; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030663937     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.10.4.742     Document Type: Review

References (206)

1. Ambrus, J. L., L. Chesky, T. Chused, Y. Young, P. McFarland, A. August, and E. J. Brown. 1991. Intracellular signaling events associated with induction of proliferation of normal human B-lymphocytes by two different antigenically related human B-cell growth factors (high molecular weight B-cell growth factor [HMW-BGF] and the complement factor 3b). J. Biol. Chem. 266:3702-3708.
2. Ambrus, J. L., C. H. Jurgensen, E. J. Brown, and A. S. Fauci. 1985. Purification to homogeneity of a high molecular weight human B-cell growth factor: demonstration of specific binding to activated B-cells: and development of a monoclonal antibody to the factor. J. Exp. Med. 162: 1319-1335.
3. Appasamy, P. M. 1993. Interleukin-7: biology and potential clinical applications. Cancer Invest. 11:487-499.
4. Arai, K., F. Lee, A. Miyajima, S. Miyatake, N. Aria, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783-836.
5. Baird, P. N., R. J. D'Andrea, and G. J. Goodall. 1995. Cytokine receptor genes: structure, chromosomal location, and involvement in human disease. Leuk. Lymphoma 18:373-383.
6. Bamford, R. N., A. J. Grant, J. D. Burton, C. Peters, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940-4944.
7. Baron, S., S. K. Tyring, W. R. Fleischmann, D. H. Coppenhaver, D. W. Niesel, G. R. Klimpel, G. J. Stanton, and T. K. Hughes. 1991. The interferons: mechanisms of action and clinical applications. JAMA 266:1375-1383.
8. Barton, B. E. 1996. The biological effects of interieukin-6. Med. Res. Rev. 16:87-109.
9. Bazzoni, F., and B. Beutler. 1995. How do tumor necrosis factors work? J. Inflamm. 45:221-238.
10. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725.
11. Beagley, K., J. Eldridge, F. Lee, H. Kiyono, M. Everson, W. Koopman, T. Hirano, T. Kishimoto, and J. McGhee. 1989. Interleukins and IgA synthesis: human and murine interleukin-6 induce high rate IgA secretion in IgA-committed B-cells. J. Exp. Med. 169:2133-2138.
12. Bendtzen, K., M. B. Hansen, C. Ross, L. K. Poulsen, and M. Svenson. 1995. Cytokines and autoantibodies to cytokines. Stem Cells (Dayton) 13:206-222.
13. Berg, D. J., R. Kuehn, K. Rajewski, W. Mueller, S. Menon, N. Davidson, G. Gruenig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Schwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96:2339-2347.
14. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7:625-655.
15. Biron, C. A., and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485-496.
16. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
17. Borger, P., H. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. IL-7 differentially modulates the expression of IFN-γ and IL-4 in activated human T-lymphocytes by transcriptional and post-transcriptional mechanisms. J. Immunol. 156:1333-1338.
18. Borish, L., R. Rosenbaum, L. Albury, and S. Clark. 1989. Activation of neutrophils by recombinant interleukin-6. Cell. Immunol. 121:280-289.
19. Bradding, P. 1996. Human mast cell cytokines. Clin. Exp. Allergy 26:13-19.
20. Bromander, A. K., L. Ekman, M. Kopf, J. G. Nedrud, and N. Y. Lycke. 1996. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J. Immunol. 156:4290-4297.
21. Brooks, J. W., and S. B. Mizel. 1994. Interleukin-1 signal transduction. Eur. Cytokine Netw. 6:547-561.
22. Brouckaert, P., C. Libert, B. Everaerdt, N. Takahashi, A. Cauwels, and W. Fiers. 1993. Tumor necrosis factor, its receptors and the connection with interleukin-1 and interleukin-6. Immunobiology 187:317-329.
23. Brown, P. M., P. Tagari, K. R. Rowan, V. L. Vu, G. P. Oneill, R. C. Middaugh, G. Sanyal, A. W. Ford-Hutchinson, and D. W. Nicholson. 1995. Epitope-labeled soluble human interleukin-5 (IL-5) receptors - affinity cross-link labeling, IL-5 binding and biological activity. J. Biol. Chem. 270:29236-29243.
24. Broxmeyer, H. E., S. Cooper, N. Hague, L. Benninger, A. Sarris, K. Cornetta, S. Vadhanraj, P. Hendrie, and C. Mantel. 1995. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann. Hematol. 71:235-246.
25. Bruce, A. G., P. S. Linsley, and T. M. Rose. 1992. Oncostatin M. Prog. Growth Factor Res. 4:157-170.
26. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280-288.
27. Bucala, R. 1994. Identification of MIF as a new pituitary hormone and macrophage cytokine and its role in endotoxic shock. Immunol. Lett. 43: 111-123.
28. Butterworth, A. E. 1984. Cell mediated damage to helminths. Adv. Parasitol. 23:143-235.
29. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin-15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578-2582.
30. Center, D. M., H. Kornfeld, and W. W. Cruikshank. 1996. Interleukin-16 and its function as a CD4 ligand. Immunol. Today 17:476-481.
31. Chazen, G. D., G. M. Pereira, G. Legros, S. Gillis, and E. M. Shevach. 1989. Interleukin 7 is a T-cell growth factor. Proc. Natl. Acad. Sci. USA 86:5923-5927.
32. Chen, C. C., and A. M. Manning. 1996. TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 8:58-65.
33. Clark-Lewis, I., K. S. Kim, K. Rajarathnam, J. H. Gong, B. Dewald, B. Moser, M. Baggiolini, and B. D. Sykes. 1995. Structure-activity relationships of chemokines. J. Leukocyte Biol. 57:703-711.
34. Clayberger, C., S. Luna Fineman, J. E. Lee, A. Pillai, M. Campbell, R. Levy, and A. M. Krensky. 1992. Interleukin 3 is a growth factor for human follicular B cell lymphoma. J. Exp. Med. 175:371-376.
35. Cluitmans, F. H. M., B. H. J. Esendam, J. E. Landegent, R. Willemze, and J. H. F. Falkenburg. 1994. IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes. Ann. Hematol. 68:293-298.
36. Combadiere, C., S. K. Ahuja, J. Vandamme, H. L. Tiffany, J. L. Gao, and P. M. Murphy. 1995. Monocyte chemoattractant protein-3 is a functional ligand for C-C chemokine receptors 1 and 2B. J. Biol. Chem. 270:29671-29675.
37. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin-12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634-639.
38. Crowe, P. D., T. L. van Arsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-beta-specific receptor. Science 264:707-710.
39. Curfs, J. H. A. J., M. T. E. Vogels, W. M. C. Eling, and J. W. M. van der Meer. 1992. IL-1 receptor antagonist prevents cerebral malaria in Plasmodium berghei-infected mice, p. 105-111. In P. Ghezzi and A. Mantovani (ed.), The pathophysiology and pharmacology of cytokines. Biomedical Press, Augusta, Ga.
40. Daig, R., T. Andus, E. Aschenbrenner, W. Falk, J. Scholmerich, and V. Gross. 1996. Increased interleukin-8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216-222.
41. Dale, D. C., W. C. Liles, W. R. Summer, and S. Nelson. 1995. Review: granulocyte colony-stimulating factor (G-CSF) - role and relationships in infectious diseases. J. Infect. Dis. 172:1061-1075.
42. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
43. Dalrymple, S. A., R. Slattery, D. M. Aud, M. Krishna, L. A. Lucian, and R. Murray. 1996. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64:3231-3235.
44. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γ-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
45. Danilkovich, A. V., and B. B. Dzantiev. 1995. Interaction of cytokines with cellular receptors. Biochemistry (Engl. Transl. Biokhimiya) 60:1051-1060.
46. Dayer, J.-M., and D. Burger. 1994. Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur. Cytokine Netw. 5:563-571.
47. Defrance, T., P. Carayon, and G. Billian. 1994. Interleukin-13 is a B-cell stimulating factor. J. Exp. Med. 179:135-143.
48. Dejong, J. L. O., N. L. Farner, M. B. Widmer, J. G. Giri, and P. M. Sondel. 1996. Interaction of IL-15 with the shared IL-2 receptor β and γ(c) subunits - the IL-15/β/γ(c) receptor-ligand complex is less stable than the IL-2/β/γ(c) receptor-ligand complex. J. Immunol. 156:1339-1348.
49. Devergne, O., M. Hummel, H. Koeppen, M. M. Le Beau, E. C. Nathanson, E. Kieff, and M. Birkenbach. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70:1143-1153.
50. de Waal-Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennet, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J. Immunol. 151:6370-6381.
51. Dinarello, C. A., and S. M. Wolff. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328:106-113.
52. Dinarello, C. A. 1994. The biological properties of interleukin-1. Eur. Cytokine Netw. 5:517-531.
53. Dinarello, C. A. 1994. Interleukin-1 antagonists. J. Interferon Res. 14:307.
54. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314-1325.
55. Dinarello, C. A. 1995. Interleukin-1 and interleukin-1 receptor antagonists. Nutrition 11:492-494.
56. Disanto, J. P., R. Kuhn, and W. Muller. 1995. Common cytokine receptor gamma chain γ(c)-dependent cytokines: understanding in vivo functions by gene targeting. Immunol. Rev. 148:19-34.
57. Dittmar, M. T., A. McKnight, G. Simmons, P. R. Clapham, R. A. Weiss, and P. Simmonds. 1997. HIV tropism and co-receptor use. Nature 385:495-496.
58. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735-741.
59. Dunkley, M. L., and A. J. Husband. 1991. The role of non-B-cells in localizing an IgA plasma cell response in the intestine. Reg. Immunol. 3:336-345.
60. Ertel, W., M. Keel, U. Steckholzer, U. Ungethum, and O. Trentz. 1996. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch. Surg. 131:51-56.
61. Eugster, H.-P., M. Müller, U. Karrer, B. D. Carr, B. Schnyder, V. M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, R. Zinkernagel, H. Bluethmann, and B. Ryffel. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8:23-36.
62. Falus, A. 1995. Cytokine receptor architecture, structure and genetic assembly. Immunol. Lett. 44:221-223.
63. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571-611.
64. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
65. Fiorenzo, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T-helper cell. J. Exp. Med. 170:2081-2095.
66. Fleming, S. D., and P. A. Campbell. 1996. Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity. J. Immunol. 156: 1143-1150.
67. H2? Science 275:1615.
68. Ganser, A., B. Volkers, J. Greher, O. G. Ottmann, F. Walther, R. Becher, L. Bergmann, G. Schulz, and D. Hoelzer. 1989. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes: a phase I/II trial. Blood 73:31-37.
69. Garcia-Zepeda, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi, F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP) 4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR) 2 and 3. J. Immunol. 157:5613-5626.
70. Gasperini, S., F. Calzetti, M. P. Russo, M. Degironcoli, and M. A. Cassatella. 1995. Regulation of GRO-α production in human granulocytes. J. Inflamm. 45:143-151.
71. Geist, L. J., and G. W. Hunninghake. 1995. Cytokine gene regulation by viral gene products. J. Lab. Clin. Med. 126:517-520.
72. Giri, J. G., D. M. Anderson, S. Kumaki, L. S. Park, K. H. Grabstein, and D. Cosman. 1995. 1L-15, a novel T-cell growth factor that shares activities and receptor components with IL-2. J. Leukocyte Biol. 57:763-766.
73. Gleich, G. J., and C. R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39:177-253.
74. Glickstein, L. J., and B. T. Huber. 1995. Karoushi - death by overwork in the immune system. J. Immunol. 155:522-524.
75. Gordon, M. S. 1996. Thrombopoietic activity of recombinant human interleukin-11 in cancer patients receiving chemotherapy. Cancer Chemother. Pharmacol. 38:S96-S98.
76. Gordon, M. S., W. J. McCaskill-Stevens, L. A. Battiato, J. Loewy, D. Loesch, E. Breeden, R. Hoffman, K. J. Beach, B. Kuca, J. Kaye, and G. W. Sledge. 1996. Phase I trial of recombinant human interleukin-11 (neumega rh IL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615-3624.
77. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Shoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Jiri. 1994. Cloning of a T-cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-968.
78. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802.
79. Grimm, M. C., S. K. O. Elsbury, P. Pavli, and W. F. Doe. 1996. Interleukin-8: cells of origin in inflammatory bowel disease. Gut 38:90-98.
80. Groopman, J. E., J. M. Molina, and D. T. Scadden. 1989. Hematopoietic growth factors: biology and clinical applications. N. Engl. J. Med. 321:1449-1459.
81. Gruss, H. J., and S. K. Dower. 1995. The TNF ligand superfamily and its relevance for human diseases. Cytokine Mol. Ther. 1:75-105.
82. Hansen, M. B., M. Svenson, M. Diamant, K. Abell, and K. Bendtzen. 1995. Interieukin-6 autoantibodies: possible biological and clinical significance. Leukemia 9:1113-1115.
83. Hauser, S. L. 1995. Tumor necrosis factor: immunogenetics and disease. Ann. Neurol. 38:702-704.
84. He, Y.-W., B. Adkins, R. K. Furse, and T. R. Malek. 1995. Expression and function of the γc subunit of the IL-2, IL-4, and IL-7 receptors. J. Immunol. 154:1596-1605.
85. Heaney, M. L., and D. W. Golde. 1996. Soluble cytokine receptors. Blood 87:847-857.
86. Heldin, C. H. 1992. Structural and functional studies on platelet-derived growth factor. EMBO J. 11:4251-4259.
87. Hendrzak, J. A., and M. J. Brunda. 1995. Biology of disease. Interleukin-12: biologic activity, therapeutic utility, and role in disease. Lab. Invest. 72:619-637.
88. Herrod, H. G. 1989. Interleukins in immunologic and allergic diseases. Ann. Allergy 63:269-272.
89. Hibi, M., K. Nakajima, and T. Hirano. 1996. IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med. 74:1-12.
90. Hirao, T., H. Aoki, H. Ichikawa, and Y. Sato. 1997. Characterization of an interleukin-1 receptor antagonist protein released from ultraviolet irradiated epidermal sheet. J. Dermatol. Sci. 14:189-198.
91. Horak, I., J. Lohler, A. Ma, and K. A. Smith. 1995. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148:35-44.
92. Howard, M., J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T. Hamaoka, and W. E. Paul. 1982. Identification of a T-cell-derived B-cell growth factor distinct from interleukin-2. J. Exp. Med. 155:914-920.
93. Huhn, R. D., E. Radwanski, S. M. O'Connell, M. G. Sturgill, L. Clarke, R. P. Cody, M. B. Affrime, and D. L. Cutler. 1996. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human imerleukin-10 in healthy volunteers. Blood 87:699-705.
94. Idzerda, R. L., C. J. March, B. Mosley, S. D. Lyman, T. vanden Bos, S. D. Gimpel, W. S. Din, K. H. Grabstein, M. B. Widmer, L. S. Park, D. Cosman, and M. P. Beckmann. 1990. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171:861-873.
95. Ihle, J., B. Witthuhn, F. Quelle, K. Yamamoto, W. Thierfelder, B. Kreider, and O. Silvennoinen. 1994. Signaling by the cytokine receptor superfamily: Jaks and Stats. Trends Biochem. Sci. 19:222-227.
96. Joyce, D. A., and J. H. Steer. 1996. IL-4, IL-10 and IFN-γ have distinct, but interacting, effects on differentiation-induced changes in TNF-α and TNF receptor release by cultured human monocytes. Cytokine 8:49-57.
97. Jullien, D., P. A. Sieling, K. Uyemure, N. D. Mar, T. H. Rea, and R. L. Modlin. 1997. IL-15, an immunomodulator of T-cell responses in intracellular infection. J. Immunol. 158:800-806.
98. Karnitz, L. M., and R. T. Abraham. 1995. Cytokine receptor signaling mechanisms. Curr. Opin. Immunol. 7:320-326.
99. H1 clone. Cell. Immunol. 176:50-58.
100. Kawashima, I., and Y. Takiguchi. 1992. Interleukin-11: a novel stromaderived cytokine. Prog. Growth Factor Res. 4:191-206.
101. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-1399.
102. Kim, C., C. Schinkel, D. Fuchs, J. Stadler, A. Walz, S. Zedler, G. H. Von Donnersmarck, and E. Faist. 1995. Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch. Surg. 130:1330-1336.
103. Kishimoto, T. 1992. Interleukin-6 and its receptor; from cloning to clinic. Int. Arch. Allergy Immunol. 99:172-177.
104. Kishimoto, T., S. Akira, M. Narazaki, and T. Taga. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
105. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258:593-597.
106. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell 76:253-262.
107. Knall, C., S. Young, J. A. Nick, A. M. Buhl, G. S. Worthen, and G. L. Johnson. 1996. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271:2832-2838.
108. Komschlies, K. L., K. J. Grzegorzewski, and R. H. Wiltrout. 1995. Diverse immunological and hematological effects of interleukin 7: implications for clinical application. J. Leukocyte Biol. 58:623-633.
109. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Köhler. 1994. Impaired acute phase and immune responses in interleukin-6-deficient mice. Nature 368:339-342.
110. Kopf, M., G. Legros, A. J. Coyle, M. Koscovilbois, and F. Brombacher. 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148:45-69.
111. Kosugi, H., Y. Nakagawa, K. Arai, and T. Yokota. 1995. Gene structures of the α-subunits of human IL-3 and granulocyte-macrophage colony-stimulating factor receptors: comparison with the cytokine receptor superfamily. J. Allergy Clin. Immunol. 96:1115-1125.
112. Kunimoto, D., R. Nordan, and W. Strober. 1989. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J. Immunol. 143: 2230-2239.
113. Kunkel, S. L., L. Lukacs, and R. M. Strieter. 1995. Expression and biology of neutrophil and endothelial cell-derived chemokines. Cell Biol. 6:327-336.
114. Kurzrock, R., M. Wetzler, Z. Estrov, and M. Talpaz. 1995. Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias. Cytokine Mol. Ther. 1:177-184.
115. + T-cells in vitro. J. Immunol. 156:310-315.
116. Lee, J. D., K. Rhoades, and J. S. Economou. 1995. Interleukin-4 inhibits the expression of tumour necrosis factors α and β, interleukins-1β and -6 and interferon-γ. Immunol. Cell Biol. 73:57-61.
117. Lemmel, E. M., D. Brackertz, M. Franke, W. Gaus, P. W. Hartl, K. Machalke, H. Mielke, H. J. Obert, H. H. Peter, and J. Sieper. 1988. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol. Int. 8:87-93.
118. Leonard, W. J., E. W. Shores, and P. E. Love. 1995. Role of the common cytokine receptor γ-chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:97-114.
119. Lieschke, G. J., and A. W. Burgess. 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 327:99-106.
120. Lieschke, G. J., D. Maher, J. Cebon, M. O'Connor, M. Green, W. Sheridan, A. Boyd, M. Rallings, E. Bonnem, and D. Metcalf. 1989. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Ann. Intern. Med. 110:357-364.
121. Liles, W. C., and C. van Voorhis. 1995. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Infect. Dis. 172:1573-1580.
122. Lin, J.-X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, Z. Li, A. Yamauchi, E. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:1-23.
123. Lin, R., P. E. Tarr, and T. C. Jones. 1995. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin. Infect. Dis. 21:1439-1449.
124. Lindemann, A., and R. Mertselmann. 1993. Interleukin-3: structure and function. Cancer Invest. 11:609-623.
125. Locksley, R. M. 1993. Interleukin-12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90:5879-5880.
126. Lucey, D. R., M. Clerici, and G. M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:532-562.
127. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and dead. J. Leukocyte Biol. 55:401-409.
128. McInnes, I. B., J. Almughales, M. Field, B. P. Leung, F. P. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175-182.
129. McMillen, M. A., and B. E. Sumpio. 1995. Endothelins: polyfunctional cytokines. J. Am. Coll. Surg. 180:621-637.
130. Mehler, M. F., R. Rozental, M. Dougherty, D. C. Spray, and J. A. Kessler. 1993. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362:62-65.
131. Merz, H., F. A. Houssiau, K. Orscheschek, J. C. Renauld, A. Fliedner, M. Herin, H. Noel, M. Kadin, H. K. Mueller Hermelink, and J. van Snick. 1991. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311-1317.
132. Metcalf, D. 1992. Leukemia inhibitory factor - α puzzling polyfunctional regulator. Growth Factors 7:169-173.
133. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fuji, M. Ikeda, S. Fukuda, and M. Kurimoto. 1996. Interferon gamma inducing factor enhances T helper 1 cytokine production by stimulated human T-cells: synergism with interleukin-12 for interferon gamma production. Eur. J. Immunol. 26:1647-1651.
134. Miller, D. K., J. Myerson, and J. W. Becker. 1997. The interleukin-1β converting enzyme family of cysteine proteases. J. Cell. Biochem. 64:2-10.
135. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17-46.
136. Minami, Y., T. Kono, T. Miyazaki, and T. Taniguchi. 1993. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11:245-267.
137. Minty, A., P. Chalon, J.-M. Derocq, X. Dumont, J.-C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, and D. Caput. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248-250.
138. Moore, K. W., A. O'Garra, R. de Waal-Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
139. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1-26.
140. Motoyoshi, K. 1994. Macrophage colony-stimulating factor for cancer therapy. Oncology 51:198-204.
141. Mukaida, N., A. Harada, K. Yasumoto, and K. Matsushima. 1992. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol. Immunol. 36:773-789.
142. Murata, T., P. D. Noguchi, and R. K. Puri. 1995. Receptors for interleukin (IL)-4 do not associate with the common γ-chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem. 270:30829-30836.
143. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
144. Muzio, M., N. Polentarutti, M. Sironi, G. Poli, L. De Gioia, M. Introna, A. Mantovani, and F. Colotta. 1995. Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist. J. Exp. Med. 182:623-628.
145. Nakano, H., H. Oshima. W. Chung, L. Williams Abbott, C. F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem. 271:14661-14664.
146. Namen, A. E., D. E. Williams, and R. G. Goodwin. 1990. Interleukin-7: a new hematopoietic growth factor. Prog. Clin. Biol. Res. 338:65-73.
147. Neben, S., and K. Turner. 1993. The biology of interleukin-11. Stem Cells 11:156-162.
148. Nishimura, H., K. Hiromatsu, N. Kobayashi, K. H. Grabstein, R. Paxton, K. Sugamura, J. A. Bluestone, and Y. Yoshikai. 1996. IL-15 is a novel growth factor for murine γδ T-cells induced by Salmonella infection. J. Immunol. 156:663-669.
149. Obiri, N. I., P. Leland, T. Murata, W. Debinski, and R. K. Puri. 1997. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 158:756-764.
150. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T-cells. Nature 378:88-91.
151. Oneill, L. A. J. 1995. Interleukin-1 signal transduction. Int. J. Clin. Lab. Res. 25:169-177.
152. Page, L. A., M. S. Topp, R. Thorpe, and A. R. Miresluis. 1996. An antiproliferative bioassay for interleukin-4. J. Immunol. Methods 189:129-135.
153. Parada, N. A., W. W. Cruikshank, H. L. Danis, T. C. Ryan, and D. M. Center. 1996. IL-16-and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell. Immunol. 168:100-106.
154. Paul, W. E. 1991. Interleukin-4: a prototype immunoregulatory lymphokine. Blood 77:1859-1870.
155. Pfeilschifter, J. 1994. Cytokines and signal transduction. Clin. Invest. 72: 713-714.
156. Poltorak, A. N., F. Bazzoni, I. I. Smirnova, E. Alejos, P. Thompson, G. Luheshi, N. Rothwell, and B. Beutler. 1995. MIP-1 gamma: molecular cloning, expression, and biological activities of a novel C-C chemokine that is constitutively secreted in vivo. J. Inflamm. 45:207-219.
157. Ponzoni, M., A. Casalaro, M. Lanciotti, P. G. Montaldo, and P. Cornaglia Ferraris. 1992. The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res. 52:931-939.
158. Proost, P., A. Wuyts, and J. Vandamme. 1996. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J. Leukocyte Biol. 59:67-74.
159. Renauld, J. C., F. Houssiau, J. Louahed, A. Vink, J. van Snick, and C. Uyttenhove. 1993. Interleukin-9. Adv. Immunol. 54:79-97.
160. Richards, C. D., C. Langdon, D. Pennica, and J. Gauldie. 1996. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J. Interferon Cytokine Res. 16:69-75.
161. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
162. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, C. Toniatti, P. Puccetti, F. Bistoni, and V. Poli. 1996. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345-1355.
163. Ross, R., E. W. Raines, and D. F. Bowen-Pope. 1986. The biology of platelet-derived growth factor. Cell 46:155-169.
164. Roth, S. J., M. W. Carr, and T. A. Springer. 1995. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T-lymphocytes. Eur. J. Immunol. 25:3482-3488.
165. Russell, S. M., A. D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M. C. Freedman, A. Miyajima, R. K. Puri, W. E. Paul, and W. J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 262:1880-1884.
166. Ryffel, B. 1996. Gene knockout mice as investigative tools in pathophysiology. Int. J. Exp. Pathol. 77:125-141.
167. Sanderson, C. J., H. D. Campbell, and I. G. Young. 1988. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol. Rev. 102:29-50.
168. Schall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165-183.
169. Schindler, C. 1995. Cytokine signal transduction. Receptor 5:51-62.
170. Sechler, J. M., H. L. Malech, C. J. White, and J. I. Gallin. 1988. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc. Natl. Acad. Sci. USA 85:4874-4878.
171. Sengupta, T. K., E. M. Schmitt, and L. B. Ivashkiv. 1996. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc. Natl. Acad. Sci. USA 93:9499-9504.
172. Sharma, S., S. Metha, J. Morgan, and A. Maizel. 1987. Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli. Science 235:1489-1493.
173. Sims, J. E., and S. K. Dower. 1994. Interleukin-1 receptors. Eur. Cytokine Netw. 5:539-546.
174. Sims, J. E., M. A. Gayle, J. L. Slack, M. R. Alderson, T. A. Bird, J. G. Giri, F. Colotta, F. Re, A. Mantovani, K. Shanebeck, K. H. Grabstein, and S. K. Dower. 1993. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90:6155-6159.
175. Sosroseno, W., and E. Herminajeng. 1995. The immunoregulatory roles of transforming growth factor beta. Br. J. Biomed. Sci. 52:142-148.
176. Stern, A. S., J. Magram, and D. H. Presky. 1996. Interleukin-12: an integral cytokine in the immune response. Life Sci. 58:639-654.
177. Stevens, D. L. 1995. Cytokines: an updated compendium. Curr. Opin. Infect. Dis. 8:175-180.
178. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K. Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleukin-2 receptor γ chain: its role in the multiple cytokine receptor complexes and T-cell development in XSCID. Annu. Rev. Immunol. 14:179-205.
179. Tafuto, S., I. Silvestri, P. D'Andrea, D. Ronga, and G. Abate. 1994. Interleukin-6: biological features and clinical implications. J. Biol. Regul. Homeostatic Agents 8:1-8.
180. Tai, P. C., S. J. Ackerman, C. J. Spry, S. Dunnette, E. G. Olsen, and C. J. Gleich. 1987. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet i:643-647.
181. Takatsu, K., A. Tominaga, N. Harada, S. Mita, M. Matsumoto, T. Takahashi, Y. Kikuchi, and N. Yamaguchi. 1988. T-cell-replacing factor (TRF)/ interleukin-5
182. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T-lymphocytes and promotes T-cell adhesion to endothelial cells. J Exp. Med. 177:1809-1814.
183. Taub, D. D., J. R. Ortalo, S. M. Turkovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukocyte Biol. 59: 81-89.
184. Thornberry, N. A. 1994. Interleukin-1β converting enzyme. Methods Enzymol. 244:615-631.
185. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317-343.
186. H1 cells. Immunol. Today 14:335-338.
187. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells tvpe 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
188. van der Meer, J. W. M., M. T. E. Vogels, J. H. A. J. Curfs, and W. M. C. Eling. 1993. Interleukin-1 as a possible agent for treatment of infection. Eur. J. Clin. Microbiol. Infect. Dis. 12:S73-S77.
189. van der Meer, J. W. M., M. T. E. Vogels, J. H. A. J. Curfs, B.-J. Kullberg, and W. M. C. Eling. 1993. Interleukin-1 and its receptor antagonist as candidate therapeutic agents for severe infections, p. 332-337. In H. Redl and D. L. Traber (ed.), Shock, sepsis, and organ failure. Springer Verlag, Berlin, Germany.
190. van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8: 253-278.
191. Van Vlasselaer, P. 1992. Leukemia inhibitory factor (LIF): a growth factor with pleiotropic effects on bone biology. Prog. Growth Factor Res. 4:337-353.
192. Viale, G., and D. Vercelli. 1995. Interleukin-13 regulates the phenotype and function of human monocytes. Int. Arch. Allergy Immunol. 107:176-178.
193. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor: new insights into the molecular mechanism of its multiple actions. J. Biol. Chem. 266:7313-7316.
194. Vogels, M. T. E., I. J. D. Lindley, J. H. A. J. Curfs, W. M. C. Eling, and J. W. M. van der Meer. 1993. Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob. Agents Chemother. 37:276-280.
195. Wang, W. Z., H. J. Chen, K. N. Giedd, A. Schwartz, P. J. Cannon, and L. E. Rabbani. 1995. T-cell lymphokines, interleukin-4 and γ-interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor. Circ. Res. 77:1095-1106.
196. Watkins, L. R., S. F. Maier, and L. E. Goehler. 1995. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289-302.
197. + hematopoietic progenitor cells. Blood 88:2549-2558.
198. Weiergraber, O., U. Hemmann, A. Kuster, G. Mullernewen, J. Schneider, S. Rosejohn, P. Kurschat, J. P. J. Brakenhoff, M. H. L. Hart, S. Stabel, and P. C. Heinrich. 1995. Soluble human interleukin-6 receptor - expression in insect cells, purification and characterization. Eur. J. Biochem. 234:661-669.
199. Weiss, T., M. Grell, B. Hessabi, S. Bourteele, G. Müller, P. Scheurig, and H. Wajant. 1997. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80. J. Immunol. 158:2398-2404.
200. Wells, J. A. 1996. Binding in the growth hormone receptor complex. Proc. Natl. Acad. Sci. USA 93:1-6.
201. Wells, T. N. C., C. A. Power, M. Lustinarasimhan, A. J. Hoogewerf, R. M. Cooke, C. W. Chung, M. C. Peitsch, and A. E. I. Proudfoot. 1996. Selectivity and antagonism of chemokine receptors. J. Leukocyte Biol. 59:53-60.
202. Williams, D. E., P. de Vries, A. E. Namen, M. B. Widmer, and S. D. Lyman. 1992. The steel factor. Dev. Biol. 151:368-376.
203. Yao, Z. B., W. C. Fanslow, M. F. Seldin, A. M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunology 3:811-821.
204. Yao, Z. B., S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, and R. J. Armitage. 1995. Human IL-17: a novel cytokine derived from T-cells. J. Immunol. 155:5483-5486.
205. Yoshimoto, T., K. Kojima, T. Funakoshi, Y. Endo, T. Fujita, and H. Nariuchi. 1996. Molecular cloning and characterization of murine IL-12 genes. J. Immunol. 156:1082-1088.
206. Zhao, Y. X., and A. Tarkowski. 1995. Impact of interferon-γ receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J. Immunol. 155:5736-5742.